|
|
Generic Drugs Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Generic Drugs Market, including, but not limited to latest trend on: Generic Drugs; Branded Medicine; Patent Expiration; Generics.
We offer market research, industry forecasts, and business analysis in the Generic Drugs Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Biosimilars: Beyond the first product wave |
|
| Table of Contents Published: 2009/10 Published by: Espicom Business Intelligence |
| The future of the pharmaceutical industry lies with biotechnology. Biotech drugs account for around 10-15% of the current pharmaceutical market, and the sector is outperforming the market as a whole in terms of growth. ... |
| Biosimilars (2009 - 2014) |
|
| Table of Contents Published: 2009/09 Published by: Markets and Markets |
| The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market. The global biosim ... |
| World Generics Market 2009-2024 |
|
| Table of Contents Published: 2009/08 Published by: Visiongain |
| The generic pharmaceuticals sector has been expanding strongly in recent years as the need for cheaper medicines worldwide has increased. The next five years from 2009 will see more leading drugs going off patent, thus increasing opportunities for generic ... |
| Generic Strategies in Emerging Markets |
|
| Table of Contents Published: 2009/08 Published by: Datamonitor |
| The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targe ... |
| Emerging Opportunities in Controlled-Release Generic Drugs |
|
| Table of Contents Published: 2009/08 Published by: Espicom Business Intelligence |
| While controlled-release products have traditionally been developed towards the patent-expiry, companies are now beginning to look at controlled-release delivery earlier in the product life-cycle and, in some cases, are launching immediate- and controlled ... |
| Generic Drug Market in Canada |
|
| Table of Contents Published: 2009/08 Published by: RNCOS E-Services Pvt. Ltd. |
| Canada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. In 2008, generics accounted for more than 51% prescriptions and around 23% sales of the total pharmaceutical market. ... |
| Booming US Generic Drug Market |
|
| Table of Contents Published: 2009/08 Published by: RNCOS E-Services Pvt. Ltd. |
| The growth of generics markets in the US is in full swing. Realizing its importance in minimizing the healthcare cost, government is also taking initiative to promote this market. Over the past ten years (1999-2008), the generic drugs have saved US$ 734 B ... |
| Generic Drugs: The Global Market |
|
| Table of Contents Published: 2009/07 Published by: BCC Research |
| The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major cou ... |
| Biosimilars and Biobetters: Positioning for a New Market |
|
| Table of Contents Published: 2009/07 Published by: Biophoenix Limited |
| This new and timely report analyzes the emerging market for first- and second-generation biosimilars. The market can best be understood in the context of the established $110 billion biologics business, which is therefore comprehensively reviewed. Current ... |
| Biosimilars Series: Forecast Analysis |
|
| Table of Contents Published: 2009/06 Published by: Datamonitor |
| The high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and immine ... |
| Generic Benchmarking: Brand Erosion at Patent Expiry |
|
| Table of Contents Published: 2009/03 Published by: Datamonitor |
| Not only is Pharma facing a continued slow down in sales growth in the seven major markets, but erosion of branded drugs by generics follow patent expiry is increasing, driven by evolving payer initiatives to incentivize generic use. ... |
| How to Forecast Generic Pharmaceutical Prices |
|
| Table of Contents Published: 2009/03 Published by: Urch Publishing, Ltd. |
| It has long been recognised that prices paid by chemists and doctors for a generic product decline in the weeks and months after generic launch and patent expiry. But calculating how quickly this happens can often only be guessed at - until now
How to ... |
| The World Generic Market Report 2009 - 7th EDition |
|
| Table of Contents Published: 2009/01 Published by: Espicom Business Intelligence |
| Corporate consolidation continues to change the operating landscape, most notably with the acquisition of Barr Pharma by Teva which has created by far the largest generics company and a major player on the global pharmaceutical stage. Big though the deal ... |
| Japanese Generic Market Forecast to 2013 |
|
| Table of Contents Published: 2009/01 Published by: RNCOS E-Services Pvt. Ltd. |
| According to Japanese Generic Market Forecast to 2013, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to regist ... |
| Generics: Global Industry Guide |
|
| Table of Contents Published: 2008/11 Published by: Datamonitor |
| Datamonitor' s Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape ... |
| World Generics Market, 2008-2013 |
|
| Table of Contents Published: 2008/11 Published by: Visiongain |
| The generics market remains a major growth area in the global healthcare market. That growth has been partly driven by cost-containment in several national healthcare sectors, with governments seeking to promote the use of generic products over higher-pri ... |
| Meeting the Challenges of Manufacturing Biosimilars |
|
| Table of Contents Published: 2008/11 Published by: Decision Resources, Inc. |
| Branded biologics have, until recently, been immune to generics competition; however, the approval of biosimilars in Europe heralds a changing landscape. Legislation enabling the approval of biosimilars is stalled in the U.S. Congress but could pass in 20 ... |
| European Biosimilars Market Outlook |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing m ... |
| Biosimilars Series: Stakeholder Analysis |
|
| Table of Contents Published: 2008/08 Published by: Datamonitor |
| Although Europe is leading the way, the biosimilar industry is very much in its infancy, with the perception of key decision makers critical to the initial rate of uptake. The opinion of key stakeholders, and the influence they wield, will therefore infor ... |
| Injectable Generic Drugs: Prospects and Opportunities to 2013 |
|
| Table of Contents Published: 2008/07 Published by: Espicom Business Intelligence |
| This report will provide industry planners, commercial developers and the investment community with a thorough review of the operating landscape for generic injectables. The report is packed with primary source information and market forecasts, and takes ... |
| CNS Generic Drugs: Prospects and Opportunities to 2012 |
|
| Table of Contents Published: 2008/04 Published by: Espicom Business Intelligence |
| This important new strategic report from Espicom evaluates the CNS generic drug market and provides detailed assessment and forecast for leading products by value to 2012, patent expiry opportunities to 2015 and competitive evaluation. ... |
| Generics Producers in Asia: Where Are the Big Opportunities |
|
| Table of Contents Published: 2008/02 Published by: Business Monitor International |
| Generics Producers in Asia: Where Are the Big Opportunities provides newly researched company profiles and competitive intelligence on 50 leading generics producers (see full list below) operating in 14 key markets: Australia, China, Hong Kong, India, Ind ... |
| Emerging Generic Drug Markets in Europe |
|
| Table of Contents Published: 2007/12 Published by: Espicom Business Intelligence |
| The four EU countries analysed in this report - France, Italy, Portugal, Spain - are expected to deliver significant double digit growth over the next 5 years and present stable, regulated operating environments with excellent prospects. ... |
| New Dynamics and Challenges in the Generics Market 2007 |
|
| Table of Contents Published: 2007/11 Published by: PJB Publications Ltd. |
| Generic drugs (generics) are now an established part of pharmaceutical markets and healthcare policies around the world. According to IMS Health data, they already account for 63% of all prescriptions dispensed in the US, the world' s largest single pharm ... |
| Business Strategies for Different Types of Biogenerics |
|
| Table of Contents Published: 2007/11 Published by: Decision Resources, Inc. |
| The rush to develop and market biogenerics has begun. While the United States dragged its feet drafting legislation to codify issues surrounding biogenerics, biogenerics companies have successfully brought products to several other markets around the worl ... |
|
| Generic Drug Business Channel |
|
| Published by: Espicom Business Intelligence |
| Concise reports on the world's major drug markets, with an emphasis on those most receptive to generics. Information is provided on the generic market, patent laws, pricing & reimbursement policies and other recent developments, where applicable. ... |
|
| BIOSIMILARS: BUSINESS REVIEW |
|
| Issues / Year: 4 Published by: Espicom Business Intelligence |
| A quarterly review that will help you navigate through the twists and turns of the emerging biosimilar market. ... |
| World Generic Markets |
|
| Issues / Year: 12 Published by: Espicom Business Intelligence |
| In recent years, the number of highly lucrative medicines coming off their patent has seen the role of the generic drugs industry change, taking an ever more important role in the pharmaceutical sector. Furthermore, the development of advanced manufacturi ... |
|
|
|
View Cart
